Alpha Tau Medical Ltd

NASDAQ DRTS

Data sourced from

and

Download Data

Alpha Tau Medical Ltd Inventory Turnover Ratio for the year ending December 31, 2023

Alpha Tau Medical Ltd Inventory Turnover Ratio is NA for the year ending December 31, 2023. The inventory turnover ratio measures the efficiency of a company's inventory management by assessing how quickly it sells and replaces its inventory. It is calculated by dividing the cost of revenue by the average inventory value. This ratio indicates the number of times the company's inventory is sold and replaced within a specific period. A higher turnover ratio suggests efficient inventory management, while a lower ratio may indicate slow sales or excess inventory.

Alpha Tau Medical Ltd Inventory Turnover Ratio for the year ending December 31, 2022 was -0.92, a -867.70% change year over year.
Alpha Tau Medical Ltd Inventory Turnover Ratio for the year ending December 31, 2021 was -0.09, a -3,196.71% change year over year.
Alpha Tau Medical Ltd Inventory Turnover Ratio for the year ending December 31, 2020 was -0.00.

NASDAQ: DRTS

Alpha Tau Medical Ltd

CEO	Mr. Uzi Sofer
IPO Date	March 8, 2021
Location	Israel
Headquarters	5 Kiryat Hamada Street, Jerusalem, Israel, 9777605
Employees	121
Sector	Healthcare
Industry	Biotechnology

Description

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.

Key trends